产品名称 |
产品编号 |
浓度/详细参数 |
CAS号 |
规格/计量单位 |
价格 |
货期 |
品牌 |
Omilancor (BT-11)
|
B413444-5mg
|
Moligand™, ≥97% |
1912399-75-7 |
5mg
|
¥ 916.9
|
现货 |
阿拉丁 |
Omilancor (BT-11)
|
B413444-25mg
|
Moligand™, ≥97% |
1912399-75-7 |
25mg
|
¥ 3127.9
|
现货 |
阿拉丁 |
BI-749327
|
B413431-5mg
|
Moligand™, ≥98% |
2361241-23-6 |
5mg
|
¥ 239.9
|
期货,请咨询 |
阿拉丁 |
BI-749327
|
B413431-25mg
|
Moligand™, ≥98% |
2361241-23-6 |
25mg
|
¥ 789.9
|
期货,请咨询 |
阿拉丁 |
Baloxavir marboxil
|
B413378-5mg
|
Moligand™, ≥97% |
1985606-14-1 |
5mg
|
¥ 451.9
|
现货 |
阿拉丁 |
Baloxavir marboxil
|
B413378-1mg
|
Moligand™, ≥97% |
1985606-14-1 |
1mg
|
¥ 262.9
|
现货 |
阿拉丁 |
Bromhexine
|
B413374-25mg
|
Moligand™, ≥98% |
3572-43-8 |
25mg
|
¥ 778.9
|
现货 |
阿拉丁 |
贝他斯汀
|
B413372-5mg
|
Moligand™, ≥98% |
125602-71-3 |
5mg
|
¥ 268.9
|
现货 |
阿拉丁 |
贝他斯汀
|
B413372-25mg
|
Moligand™, ≥98% |
125602-71-3 |
25mg
|
¥ 786.9
|
现货 |
阿拉丁 |
BIA 10-2474
|
B413370-5mg
|
Moligand™, ≥98% |
1233855-46-3 |
5mg
|
¥ 506.9
|
现货 |
阿拉丁 |
BIA 10-2474
|
B413370-25mg
|
Moligand™, ≥98% |
1233855-46-3 |
25mg
|
¥ 1741.9
|
现货 |
阿拉丁 |
Bictegravir
|
B413365-5mg
|
Moligand™, ≥99% |
1611493-60-7 |
5mg
|
¥ 240.9
|
现货 |
阿拉丁 |
磷酸巴瑞西替尼
|
B413326-25mg
|
≥98% |
1187595-84-1 |
25mg
|
¥ 599.9
|
现货 |
阿拉丁 |
苯扎氯铵
|
B413301-25mg
|
|
N/A |
25mg
|
¥ 778.9
|
期货,请咨询 |
阿拉丁 |
布康唑
|
B413277-25mg
|
≥98% |
64872-76-0 |
25mg
|
¥ 735.9
|
现货 |
阿拉丁 |
布帕维酮
|
B413201-25mg
|
≥95% |
88426-33-9 |
25mg
|
¥ 39.9
|
现货 |
阿拉丁 |
富马酸贝达喹啉
|
B413184-5mg
|
≥99% |
845533-86-0 |
5mg
|
¥ 85.9
|
现货 |
阿拉丁 |
富马酸贝达喹啉
|
B413184-25mg
|
≥99% |
845533-86-0 |
25mg
|
¥ 209.9
|
现货 |
阿拉丁 |
6-Benzylaminopurine
|
B413135-500mg
|
|
N/A |
500mg
|
¥ 2381.9
|
期货,请咨询 |
阿拉丁 |
6-Benzylaminopurine
|
B413135-100mg
|
|
N/A |
100mg
|
¥ 778.9
|
期货,请咨询 |
阿拉丁 |
BDP5290
|
B413123-25mg
|
≥98% |
1817698-21-7 |
25mg
|
¥ 4749.9
|
现货 |
阿拉丁 |
枸橼酸铋钾
|
B413092-50mg
|
≥98% |
880149-29-1 |
50mg
|
¥ 699.9
|
期货,请咨询 |
阿拉丁 |
BMS-986020
|
B413030-5mg
|
Moligand™, ≥99% |
1257213-50-5 |
5mg
|
¥ 336.9
|
现货 |
阿拉丁 |
BMS-986020
|
B413030-25mg
|
Moligand™, ≥99% |
1257213-50-5 |
25mg
|
¥ 1261.9
|
现货 |
阿拉丁 |
-
联系客服
-
-
回到顶部